This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WuXi PharmaTech (Cayman) Management Discusses Q2 2012 Results - Earnings Call Transcript

WuXi PharmaTech (Cayman) (WX)

Q2 2012 Earnings Call

August 14, 2012 8:00 am ET

Executives

Ronald Aldridge - Director of Investor Relations

Ge Li - Co-Founder, Chairman, Chief Executive Officer, Member of Strategy Committee and Member of Compensation Committee

Edward Hu - Chief Financial Officer and Chief Operating Officer

Analysts

Ingrid Yin - Oppenheimer & Co. Inc., Research Division

Ramesh C. Donthamsetty - JP Morgan Chase & Co, Research Division

David H. Windley - Jefferies & Company, Inc., Research Division

Roberto Fatta

Timothy C. Evans - Wells Fargo Securities, LLC, Research Division

Katherine Lu - Cowen and Company, LLC, Research Division

Bin Li - Morgan Stanley, Research Division

B. Kemp Dolliver - Religare Capital Markets, Research Division

Hao Zhou - Piper Jaffray Companies, Research Division

Shaojing Tong - BofA Merrill Lynch, Research Division

Wei Du - Goldman Sachs Group Inc., Research Division

Jack Hu - Deutsche Bank AG, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by and welcome to the WuXi PharmaTech Second Quarter 2012 Earnings Conference Call. [Operator Instructions] I must advise you that this conference is being recorded today, 14th of August, 2012. I would now like to hand the conference over to your speaker for today, Mr. Ron Aldridge. Sir, please go ahead.

Ronald Aldridge

Thank you, Jorge, and good morning or good evening, to everyone participating in our second quarter 2012 earnings conference call. Hosting this conference call today is Dr. Ge Li, Chairman and Chief Executive Officer. Joining him is Edward Hu, our Chief Financial Officer.

During today's presentation and question-and-answer session, we will make forward-looking statements. These forward-looking statements represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and partially are completely outside our control. I would also like you to refer to the risk factors inherent in our business that you see here and that have been filed with the SEC and are on our company website under the Investor Relations section. Actual results can be materially different from any forward-looking statements we make today.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs